Michael D. Blaszyk - 05 Jun 2023 Form 4 Insider Report for ImmunityBio, Inc. (IBRX)

Reporting relationship: Director
Issuer ticker: IBRX
Reported as of: 05 Jun 2023
Net transaction value: +$198,023
SEC form: 4
Accepted by SEC: 05 Jun 2023, 21:52:51 UTC
Prior SEC filing: 15 Jun 2022
Next SEC filing: 15 Jun 2023
Source filing: View source filing
Reporting owner signature: /s/ Jason Liljestrom, as Attorney-in-Fact

Key filing fact

Michael D. Blaszyk filed Form 4 for ImmunityBio, Inc. (IBRX) on 05 Jun 2023.

Key facts

This page summarizes Michael D. Blaszyk's Form 4 filing for ImmunityBio, Inc. (IBRX).
3 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 05 Jun 2023, 21:52.

Change

Previous filing in this sequence was filed on 15 Jun 2022.
Current net transaction value: +$198,023.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IBRX transaction

Common Stock

Purchase

Transaction value: $63,730
Shares: +23,430
Change %
Price: $2.72
Shares after: 23,430
Date: 05 Jun 2023
Ownership: By trust

IBRX transaction

Common Stock

Purchase

Transaction value: $132,960
Shares: +48,000
Change %: +205%
Price: $2.77
Shares after: 71,430
Date: 05 Jun 2023
Ownership: By trust

IBRX transaction

Common Stock

Purchase

Transaction value: $1,334
Shares: +485
Change %: +0.68%
Price: $2.75
Shares after: 71,915
Date: 05 Jun 2023
Ownership: By trust

IBRX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 193,667
Date: 05 Jun 2023
Ownership: Direct

^* marks a reported price that did not pass the local price check.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .